Cst7, a lysosomal protease inhibitor, has been shown to modulate microglial inflammatory responses in tauopathy models, while Clec7a (Dectin‐1) mediates amyloid‐beta phagocytosis (Rasmussen et al. 2022). This evidence concerns the gene CST7 and tauopathy.